首页 | 本学科首页   官方微博 | 高级检索  
检索        

我院2004-2008年降血脂药应用分析
引用本文:徐元杰,郭绍来,魏宇宁.我院2004-2008年降血脂药应用分析[J].中国药物应用与监测,2010,7(3):155-157.
作者姓名:徐元杰  郭绍来  魏宇宁
作者单位:解放军总医院药品保障中心,北京,100853
摘    要:目的:了解我院降血脂药应用情况及发展趋势,为临床合理用药提供参考依据。方法:对我院2004-2008年降血脂药用药金额、用药频度及日均费用进行统计、分析。结果:我院2004-2008年间降血脂药用药金额年均增长率为57.57%,用药频度不断升高。2008年用药频度居前十位的降脂药中他汀类药物有5种,其中辛伐他汀的用药金额和用药频度均排在首位。5年中,阿托伐他汀、阿昔莫司是用药频度增长速度最快的药物。结论:我院降血脂药的临床选择和使用较为安全、有效、经济。

关 键 词:降血脂药  用药金额  用药频度  日均费用  用药分析

Analysis of antihyperlipidemics used in our hospital from 2004 to 2008
Authors:XU Yuan-jie  GUO Shao-lai  WEI Yu-ning
Institution:(Department of Pharmaceutical Care,PLA General Hospital,Beijing 100853,China)
Abstract:Objective:To investigate the utilization and the development trend of antihyperlipidemics in our hospital,and provide reference for rational drug use in clinic.Methods:The consumption sum,DDDs and daily cost of antihyperlipidemics in our hospital in 2004-2008 were analyzed.Results:The average annual growth rate of consumption sum of antihyperlipidemics was 57.57% in 2004-2008,and DDDs increased year by year.There were five kinds of statins in the top 10 antihyperlipidemics in terms of DDDs in 2008,and consumption sum and DDDs of simvastatin were the highest.The growth rates of DDDs of atorvastatin and acipimox were the highest in the five years.Conclusion:Clinical utilization of antihyperlipidemics are safe,effective and economical in our hospital.
Keywords:Antihyperlipidemics  Consumption sum  DDDs  DDC  Analysis of drug use
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号